MARKET

MYOS

MYOS

MYOS RENS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.320
-0.037
-2.74%
Opening 14:30 01/27 EST
OPEN
1.340
PREV CLOSE
1.357
HIGH
1.340
LOW
1.320
VOLUME
5.52K
TURNOVER
--
52 WEEK HIGH
2.020
52 WEEK LOW
1.150
MARKET CAP
12.11M
P/E (TTM)
-3.6214
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MYOS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

MYOS News

  • MYOS RENS Technology to Provide Exciting Updates on New Product and Clinical Research at the Veterinary Meeting & Expo in Orlando, January 19-22, 2020
  • PR Newswire.01/15 12:00
  • MYOS CEO Joseph Mannello Issues Letter to Shareholders
  • PR Newswire.01/09 12:00
  • Imagine Owning MYOS RENS Technology (NASDAQ:MYOS) And Trying To Stomach The 83% Share Price Drop
  • Simply Wall St..12/23/2019 15:58
  • Albert Ahn, DVM, Expert in Animal Medicine, Joins MYOS as Strategic Adviser to Build Veterinary Business Focused on Muscle Health
  • ACCESSWIRE.12/17/2019 12:00

More

Industry

Food Processing
-0.65%
Food & Tobacco
-0.88%

Hot Stocks

Name
Price
%Change

About MYOS

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
More

Webull offers MYOS RENS Technology Inc (MYOS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.